A Step Closer to Reversing Type 1 Diabetes
McGowan Institute for Regenerative Medicine faculty member Massimo Trucco, MD, director of the Division of Immunogenetics at Children’s Hospital of Pittsburgh of UPMC and Hillman Professor of Pediatric Immunology at the University of Pittsburgh School of Medicine, is the leader of a study where, for the first time, scientists have achieved survival of islet cells and normal glucose regulation without diet restrictions or insulin injections in a diabetic non-human primate for longer than 1 year. The results of the team of scientists from Children’s Hospital, the Thomas E. Starzl Transplantation Institute, and Pitt’s School of Medicine were published in the December issue of the American Journal of Transplantation.
Recent News
- A Step Closer to Reversing Type 1 Diabetes
- Development of Heart Assist Device for Infants and Toddlers Gets $5.6 Million Boost
- McGowan Institute for Regenerative Medicine and Its People Receive Awards for Excellence
- Dr. Yoram Vodovotz Leads IBM Partnership Effort
- Dr. Katherine Verdolini Receives ASHA Prestigious Award
- VAD Helps Resting Heart Regenerate
- Dr. Philip LeDuc Discovers New Protein Function That Could Save Lives
- Working the Gray Area Between Sickness and Health
- Team Works to Assess Regeneration of Limbs and Digits
- CATER Receives Renewal Funding for 5 Years
- See In the News Archive and Search Feature